Teva boss hits out at opioid lawsuits
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva shares surge after announcing global opioid settlement
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Faces New Class Action—But Could It Afford Another Se...
Jewish Values Investors JLens Target Israeli Company
Teva's Small Print Gives Rise to Optimism | Ctech
Teva Pharmaceutical Industries – The Forward
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
Teva reaches $150 million deal with Texas to settle opioid-related claims | The Times of Israel
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Israeli drugmaker Teva to cut quarter of global work force (Update)
Teva | Partnership | Direct Relief
Articles about Teva Pharmaceuticals, Inc.
Helsinn Healthcare v. Teva USA (Decision January 22, 2019) | Subscript Law
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
